Search research articles
Contact Us
Filters
Showing results (1-10 of 58) with videos related to
Page
of 6
Sort By:
Kidney International
|
May 12, 2016
Drug discovery in focal and segmental glomerulosclerosis
Nick Pullen, Alessia Fornoni
Plos One
|
February 14, 2014
Bayesian model comparison and parameter inference in systems biology using nested sampling
Nick Pullen, Richard J Morris
The American Journal of Pathology
|
December 26, 2009
CNS elevation of vascular and not mucosal addressin cell adhesion molecules in patients with multiple sclerosis
Rachel Allavena, Suzanna Noy, Marcus Andrews, et al.
Nature Reviews. Drug Discovery
|
February 3, 2007
Preclinical safety testing of monoclonal antibodies: the significance of species relevance
Kathryn Chapman, Nick Pullen, Mark Graham, et al.
Prostaglandins & Other Lipid Mediators
|
April 17, 2012
Prostaglandin E2 stimulates cystogenesis through EP4 receptor in IMCD-3 cells
Dorit Elberg, Martin A Turman, Nick Pullen, et al.
Nature Plants
|
February 6, 2019
Growth rate regulation is associated with developmental modification of source efficiency
Nick Pullen, Naichao Zhang, Albor Dobon Alonso, et al.
Drug Discovery Today
|
January 26, 2010
The future of non-human primate use in mAb development
Kathryn L Chapman, Nick Pullen, Laura Andrews, et al.
Trends in Cancer
|
September 19, 2020
Dysregulated Ribosome Biogenesis Reveals Therapeutic Liabilities in Cancer
Slađana Bursać, Ylenia Prodan, Nick Pullen, et al.
Plos One
|
January 18, 2022
Urinary levels of pro-fibrotic transglutaminase 2 (TG2) may help predict progression of chronic kidney disease
Michelle Da Silva Lodge, Nick Pullen, Miguel Pereira, et al.
Plant Signaling & Behavior
|
August 31, 2013
Simple network motifs can capture key characteristics of the floral transition in Arabidopsis
Nick Pullen, Katja E Jaeger, Philip A Wigge, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 58) with videos related to
Sort By:
Page
of 6
Kidney International
|
May 12, 2016
Drug discovery in focal and segmental glomerulosclerosis
Nick Pullen, Alessia Fornoni
Plos One
|
February 14, 2014
Bayesian model comparison and parameter inference in systems biology using nested sampling
Nick Pullen, Richard J Morris
The American Journal of Pathology
|
December 26, 2009
CNS elevation of vascular and not mucosal addressin cell adhesion molecules in patients with multiple sclerosis
Rachel Allavena, Suzanna Noy, Marcus Andrews, et al.
Nature Reviews. Drug Discovery
|
February 3, 2007
Preclinical safety testing of monoclonal antibodies: the significance of species relevance
Kathryn Chapman, Nick Pullen, Mark Graham, et al.
Prostaglandins & Other Lipid Mediators
|
April 17, 2012
Prostaglandin E2 stimulates cystogenesis through EP4 receptor in IMCD-3 cells
Dorit Elberg, Martin A Turman, Nick Pullen, et al.
Nature Plants
|
February 6, 2019
Growth rate regulation is associated with developmental modification of source efficiency
Nick Pullen, Naichao Zhang, Albor Dobon Alonso, et al.
Drug Discovery Today
|
January 26, 2010
The future of non-human primate use in mAb development
Kathryn L Chapman, Nick Pullen, Laura Andrews, et al.
Trends in Cancer
|
September 19, 2020
Dysregulated Ribosome Biogenesis Reveals Therapeutic Liabilities in Cancer
Slađana Bursać, Ylenia Prodan, Nick Pullen, et al.
Plos One
|
January 18, 2022
Urinary levels of pro-fibrotic transglutaminase 2 (TG2) may help predict progression of chronic kidney disease
Michelle Da Silva Lodge, Nick Pullen, Miguel Pereira, et al.
Plant Signaling & Behavior
|
August 31, 2013
Simple network motifs can capture key characteristics of the floral transition in Arabidopsis
Nick Pullen, Katja E Jaeger, Philip A Wigge, et al.
Page
of 6